Search results
Results from the Health.Zone Content Network
Dr. Mark Rosenberg, president American College of Emergency Physicians. In late August, Texas hospitals were suddenly overwhelmed with an average of more than 1,700 emergency patients each day. "All of a sudden, it's an exponential rise again in the middle of the summer," stated the general medicine physician at the University of Texas Medical Hospital in Dallas. Staffing was also more of a ...
April 30, 2024 – In recent weeks, COVID-19 forecasters have reported on a new set of variants picked up in wastewater surveillance. Nicknamed FLiRT, they’re threatening to cause a new wave of ...
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom. Vaccinations began on 8 December 2020 after Margaret Keenan became the first person in the world (outside trials) to receive her first dose of two of the ...
This is the most common transmission. When an infected person coughs, sneezes, or talks, droplets or tiny particles called aerosols carry the virus into the air from their nose or mouth. Anyone ...
A new antibody treatment has been approved to help prevent COVID-19, and it will be available in a matter of days for many of the estimated 3 in every 100 people in the U.S. who have compromised ...
The World Health Organization declared the COVID-19 outbreak a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020. [3] [4] As of this edit (February 2024 [update] ) it is still unknown on precisely how humans in mainland China were initially or previously infected with the virus known as SARS-CoV-2.
In December 2023, the Centers for Disease Control and Prevention (CDC) reported that JN.1, nicknamed “Pirola,” made up 15–29% of all COVID-19 cases in the United States. By January 2024, JN ...
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.